MD
Mukeshmani Dhatchayani
About Mukeshmani Dhatchayani
Data last updated:
Mukeshmani Dhatchayani is a Director at Prosilio Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Prosilio Pharmaceuticals Private Limited reported revenue of ₹3.08 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Oct 2018 | 2018 | ₹3.08 Cr (FY 2024) | Active |
Board colleagues of Mukeshmani Dhatchayani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nilavoli | 05239560 | Prosilio Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukeshmani Dhatchayani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukeshmani Dhatchayani
Mukeshmani Dhatchayani currently holds 1 directorship: Prosilio Pharmaceuticals Private Limited (Director, since 05 Oct 2018, revenue ₹3.08 Cr (FY 2024)).
Mukeshmani Dhatchayani was first appointed on 05 Oct 2018 as Director at Prosilio Pharmaceuticals Private Limited.
The current boards of Mukeshmani Dhatchayani's companies include Nilavoli (Prosilio Pharmaceuticals Private Limited).